Cargando…

Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer

Background: Homologous recombination is an important DNA repair mechanism, which deficiency is a common feature of many cancers. Defining homologous recombination deficiency (HRD) status can provide information for treatment decisions of cancer patients. HRD score is a widely accepted method to eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xin, Wang, Qiong, Liu, Peifa, Sun, Linde, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709314/ https://www.ncbi.nlm.nih.gov/pubmed/36468004 http://dx.doi.org/10.3389/fgene.2022.1026871

Ejemplares similares

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity
por: Wang, Yanan, et al.
Publicado: (2022)

The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes
por: Štancl, Paula, et al.
Publicado: (2022)

HRD-MILN: Accurately estimate tumor homologous recombination deficiency status from targeted panel sequencing data
por: Wang, Xuwen, et al.
Publicado: (2022)

A Risk Model Developed Based on Homologous Recombination Deficiency Predicts Overall Survival in Patients With Lower Grade Glioma
por: Peng, Hao, et al.
Publicado: (2022)

Integrative Analysis Identifies a TNFα-Derived Gene Signature for Predicting Prognosis, Tumor Immunity, and Treatment Sensitivity in Gastric Cancer
por: Wang, Ke, et al.
Publicado: (2022)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Homologous Recombination Subpathways: A Tangle to Resolve
por: Elbakry, Amira, et al.
Publicado: (2021)

A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
por: Lu, Wei, et al.
Publicado: (2021)

Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma
por: Zhang, Dexin, et al.
Publicado: (2023)

Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
por: Póti, Ádám, et al.
Publicado: (2019)

High-Frequency Homologous Recombination Occurred Preferentially in Populus
por: Geng, Xining, et al.
Publicado: (2021)

TGFβ-Associated Signature Predicts Prognosis and Tumor Microenvironment Infiltration Characterization in Gastric Carcinoma
por: Liu, Siyuan, et al.
Publicado: (2022)

Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
por: Xu, Jingxuan, et al.
Publicado: (2021)

A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
por: Wang, Daodu, et al.
Publicado: (2022)

Inflammation-Related Long Non-Coding RNA Signature Predicts the Prognosis of Gastric Carcinoma
por: Zhang, ShuQiao, et al.
Publicado: (2021)

Regulators of homologous recombination repair as novel targets for cancer treatment
por: Krajewska, Małgorzata, et al.
Publicado: (2015)

A Wnt-related gene expression signature to improve the prediction of prognosis and tumor microenvironment in gastric cancer
por: Kong, Shuai, et al.
Publicado: (2022)

A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
por: Ren, Peng, et al.
Publicado: (2022)

Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients
por: Xuan, Feiyue, et al.
Publicado: (2022)

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
por: Zhuang, Shuping, et al.
Publicado: (2021)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Homologous recombination is involved in the diversity of replacement flexible genomic islands in aquatic prokaryotes
por: López-Pérez, Mario, et al.
Publicado: (2014)

Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
por: Tran, Ngoc-Tung, et al.
Publicado: (2019)

Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
por: Dai, Yin-wei, et al.
Publicado: (2022)

Gene Targeting Using Homologous Recombination in Embryonic Stem Cells: The Future for Behavior Genetics?
por: Gerlai, Robert
Publicado: (2016)

Gene Expression Noise Produces Cell-to-Cell Heterogeneity in Eukaryotic Homologous Recombination Rate
por: Liu, Jian, et al.
Publicado: (2019)

Corrigendum: Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
por: Tran, Ngoc-Tung, et al.
Publicado: (2020)

An oxidative stress-related signature for predicting the prognosis of liver cancer
por: Wang, Luling, et al.
Publicado: (2023)

Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis
por: Chen, Qian, et al.
Publicado: (2020)

Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)

Pan-Cancer Analysis Identified Homologous Recombination Factor With OB-Fold (HROB) as a Potential Biomarker for Various Tumor Types
por: Liu, Xianming, et al.
Publicado: (2022)

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs
por: Marquard, Andrea M, et al.
Publicado: (2015)

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration
por: Tsang, Erica S., et al.
Publicado: (2023)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer
por: Shao, Changxia, et al.
Publicado: (2022)

An expanded toolkit for Drosophila gene tagging using synthesized homology donor constructs for CRISPR-mediated homologous recombination
por: Kanca, Oguz, et al.
Publicado: (2022)

Pyroptosis-Related Gene Signature Predicts the Prognosis and Immune Infiltration in Neuroblastoma
por: Li, Wanrong, et al.
Publicado: (2022)

Homologous Recombination Deficiencies and Hereditary Tumors
por: Yamamoto, Hideki, et al.
Publicado: (2021)

Biomarkers for Homologous Recombination Deficiency in Cancer
por: Wagener-Ryczek, Svenja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5gsvtho7ddojjqd2sbnea5ia3